Artificial intelligence (AI) is increasingly being utilized to optimize magnetic resonance imaging (MRI) protocols. Given that image details are critical for diagnostic accuracy, optimizing MRI acquisition protocols is essential for enhancing image quality. While medical physicists are responsible for this optimization, the variability in equipment usage and the wide range of MRI protocols in clinical settings pose significant challenges. This study aims to validate the application of AI in optimizing MRI protocols using dynamic data from clinical practice, specifically DICOM metadata. To achieve this, four MRI spine exam databases were created, with the target attribute being the binary classification of image quality (good or bad). Five AI models were trained to identify trends in acquisition parameters that influence image quality, grounded in MRI theory. These trends were analyzed using SHAP graphs. The models achieved F1 performance ranging from 77% to 93% for datasets containing 292 or more instances, with the observed trends aligning with MRI theory. The models effectively reflected the practical realities of clinical MRI settings, offering a valuable tool for medical physicists in quality control tasks. In conclusion, AI has demonstrated its potential to optimize MRI protocols, supporting medical physicists in improving image quality and enhancing the efficiency of quality control in clinical practice.

Purpose: We present an updated study evaluating the performance of large language models (LLMs) in answering radiation oncology physics questions, focusing on the recently released models. Methods: A set of 100 multiple choice radiation oncology physics questions, previously created by a well-experienced physicist, was used for this study. The answer options of the questions were randomly shuffled to create "new" exam sets. Five LLMs (OpenAI o1-preview, GPT-4o, LLaMA 3.1 (405B), Gemini 1.5 Pro, and Claude 3.5 Sonnet) with the versions released before September 30, 2024, were queried using these new exam sets. To evaluate their deductive reasoning capabilities, the correct answers in the questions were replaced with "None of the above." Then, the explaining-first and step-by-step instruction prompts were used to test if this strategy improved their reasoning capabilities. The performance of the LLMs was compared with the answers from medical physicists. Results: All models demonstrated expert-level performance on these questions, with o1-preview even surpassing medical physicists with a majority vote. When replacing the correct answers with "None of the above," all models exhibited a considerable decline in performance, suggesting room for improvement. The explaining-first and step-by-step instruction prompts helped enhance the reasoning capabilities of the LLaMA 3.1 (405B), Gemini 1.5 Pro, and Claude 3.5 Sonnet models. Conclusion: These recently released LLMs demonstrated expert-level performance in answering radiation oncology physics questions, exhibiting great potential to assist in radiation oncology physics training and education.

How much is too much? These are questions that cut to the heart of a complex issue currently preoccupying senior medical physicists when it comes to the training and continuing professional development (CPD) of the radiotherapy physics workforce. What's exercising management and educators specifically is the extent to which the core expertise and domain knowledge of radiotherapy physicists should evolve to reflect – and, in so doing, best support – the relentless progress of artificial intelligence (AI) and machine-learning technologies within the radiation oncology workflow. In an effort to bring a degree of clarity and consensus to the collective conversation, the ESTRO 2022 Annual Congress in Copenhagen last month featured a dedicated workshop session entitled "Every radiotherapy physicist should know about AI/machine learning…but how much?" With several hundred delegates packed into Room D5 at the Bella Center, speakers were tasked by the session moderators with defending a range of "optimum scenarios" to align the know-how of medical physicists versus emerging AI/machine-learning opportunities in the radiotherapy clinic.

The impact of deploying Artificial Intelligence (AI) for radiation cancer therapy in a real-world clinical setting has been tested by Princess Margaret researchers in a unique study involving physicians and their patients. A team of researchers directly compared physician evaluations of radiation treatments generated by an AI machine learning (ML) algorithm to conventional radiation treatments generated by humans. They found that in the majority of the 100 patients studied, treatments generated using ML were deemed to be clinically acceptable for patient treatments by physicians. Overall, 89% of ML-generated treatments were considered clinically acceptable for treatments, and 72% were selected over human-generated treatments in head-to-head comparisons to conventional human-generated treatments. Moreover, the ML radiation treatment process was faster than the conventional human-driven process by 60%, reducing the overall time from 118 hours to 47 hours.

In response to a world in which cancer is a growing global health challenge, there is now a greater need for US Medical Physicists and other Radiation Oncology professionals across institutions to work together and be more globally engaged in the fight against cancer. There are currently many opportunities for Medical Physicists to contribute to alleviating this pressing need, especially in helping enhance access to Medical Physics Education/training and Research Excellence across international boundaries, particularly for low and middle-income countries (LMIC), which suffer from a drastic shortage of accessible knowledge and quality training programs in radiotherapy. Many Medical Physicists aremore » not aware of the range of opportunities that even with small effort could have a high impact. Faculty at the two CAMPEP-accredited Medical Physics Programs in New England: the University of Massachusetts Lowell and Harvard Medical School have developed a growing alliance to increase Access to Medical Physics Education/training and Research Excellence (AMPERE), and facilitate greater active involvement of U.S. Medical Physicists in helping the global fight against cancer and cancer disparities. In this symposium, AMPERE Alliance members and partners from Europe and Africa will present and discuss the growing global cancer challenge, the dearth of knowledge, research, and other barriers to providing life-saving radiotherapy in LMIC, mechanisms for meeting these challenges, the different opportunities for participation by Medical Physicists, including students and residents, and how participation can be facilitated to increase AMPERE for global health.